PECR
Basic information
Region (hg38): 2:215996329-216082955
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PECR gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 26 | 27 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 26 | 0 | 3 |
Variants in PECR
This is a list of pathogenic ClinVar variants found in the PECR region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-215996332-G-A | not specified | Uncertain significance (Jun 22, 2021) | ||
2-215996338-C-T | not specified | Uncertain significance (May 28, 2024) | ||
2-215996349-T-C | not specified | Uncertain significance (Aug 02, 2023) | ||
2-215996352-A-G | not specified | Uncertain significance (Feb 14, 2024) | ||
2-215996377-T-C | not specified | Uncertain significance (Sep 16, 2021) | ||
2-215996448-G-A | MREG-related condition | Likely benign (Aug 02, 2024) | ||
2-216013297-A-G | not specified | Uncertain significance (Jan 10, 2023) | ||
2-216043907-G-A | not specified | Uncertain significance (Oct 19, 2021) | ||
2-216043924-G-A | not specified | Uncertain significance (Jul 26, 2023) | ||
2-216049289-C-T | not specified | Uncertain significance (Dec 12, 2023) | ||
2-216049300-T-C | not specified | Uncertain significance (Jan 26, 2023) | ||
2-216049303-A-C | not specified | Uncertain significance (Jan 04, 2024) | ||
2-216049372-C-T | not specified | Uncertain significance (Apr 08, 2022) | ||
2-216051453-G-T | not specified | Uncertain significance (Oct 26, 2021) | ||
2-216051469-G-A | not specified | Uncertain significance (Feb 27, 2023) | ||
2-216051490-C-G | not specified | Uncertain significance (Jun 09, 2022) | ||
2-216051513-T-C | not specified | Uncertain significance (Sep 15, 2021) | ||
2-216058896-C-G | Benign (Jan 02, 2018) | |||
2-216058938-C-T | not specified | Uncertain significance (Nov 06, 2023) | ||
2-216058974-A-C | not specified | Uncertain significance (Nov 10, 2022) | ||
2-216065338-G-A | not specified | Uncertain significance (Jul 09, 2021) | ||
2-216065360-C-T | not specified | Uncertain significance (Apr 05, 2023) | ||
2-216065368-C-T | not specified | Uncertain significance (Jan 26, 2022) | ||
2-216065419-T-G | not specified | Uncertain significance (Oct 27, 2022) | ||
2-216065431-T-C | not specified | Uncertain significance (Mar 04, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PECR | protein_coding | protein_coding | ENST00000265322 | 8 | 86627 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.00e-8 | 0.361 | 125719 | 0 | 29 | 125748 | 0.000115 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0474 | 164 | 166 | 0.990 | 0.00000871 | 1949 |
Missense in Polyphen | 68 | 68.874 | 0.9873 | 767 | ||
Synonymous | -1.05 | 74 | 63.3 | 1.17 | 0.00000335 | 605 |
Loss of Function | 0.705 | 13 | 16.0 | 0.810 | 8.96e-7 | 177 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000566 | 0.000564 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.0000545 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000969 | 0.0000879 |
Middle Eastern | 0.0000545 | 0.0000544 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Participates in chain elongation of fatty acids. Has no 2,4-dienoyl-CoA reductase activity.;
- Pathway
- Peroxisome - Homo sapiens (human);Biosynthesis of unsaturated fatty acids - Homo sapiens (human);Allograft Rejection;Fatty Acid Biosynthesis;Mitochondrial LC-Fatty Acid Beta-Oxidation;Liver steatosis AOP;Metabolism of lipids;Metabolism of proteins;Alpha-oxidation of phytanate;Saturated fatty acids beta-oxidation;Peroxisomal lipid metabolism;Metabolism;Peroxisomal protein import;Fatty acid metabolism;phytol degradation
(Consensus)
Recessive Scores
- pRec
- 0.0599
Intolerance Scores
- loftool
- 0.457
- rvis_EVS
- 0.35
- rvis_percentile_EVS
- 74.49
Haploinsufficiency Scores
- pHI
- 0.0981
- hipred
- N
- hipred_score
- 0.169
- ghis
- 0.424
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.979
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pecr
- Phenotype
Gene ontology
- Biological process
- fatty acid alpha-oxidation;protein targeting to peroxisome;fatty acid biosynthetic process;phytol metabolic process;oxidation-reduction process
- Cellular component
- mitochondrion;peroxisome;peroxisomal membrane;cytosol
- Molecular function
- signaling receptor binding;2,4-dienoyl-CoA reductase (NADPH) activity;trans-2-enoyl-CoA reductase (NADPH) activity